Home › Therapeutic areas › Cardiovascular › Dilated Cardiomyopathy

Dilated Cardiomyopathy (3 companies)

Companies with an active program in Dilated Cardiomyopathy.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
LGVN Longeveron CardiovascularNeurology Rare 1 Phase 2 $7.1M 3
RCKT Rocket Pharmaceuticals CardiovascularImmunology Rare 1 Approved $236M 4
SLDB Solid Biosciences CardiovascularNeurology Rare 3 Phase 3 $695M 6